Clinical Trial: Randomized Phase II Study to Evaluate Efficacy of Web-based Patient-reported Outcome (PRO) Application in Solid Cancer Patients

U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301996) titled 'Randomized Phase II Study to Evaluate Efficacy of Web-based Patient-reported Outcome (PRO) Application in Solid Cancer Patients' on Nov. 30.

Brief Summary: This is a single-center, open-label, Phase 2 study to evaluate the feasibility of a mobile PRO and its efficacy in reducing unplanned healthcare utilization (unplanned outpatient visits, emergency department visits, and hospitalizations).

Study Start Date: Feb. 04, 2021

Study Type: INTERVENTIONAL

Condition: Solid Cancer

Intervention: DEVICE: Mobile PRO

Patients in the Mobile PRO group received instruction on symptom reporting and were asked to submit reports at baseline an...